Completed
PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy
NCT01696565
- Conditions
- Disease Attributes, Neoplasm Metastasis, Neoplasm Recurrence, +5 more
- Locations
-
- Tri-Service General Hospital Taipei, Taiwan